Expired Tender USA ICB TOT Ref. 146116897

Notice of Intent to Sole Source the Procurement Tender - 146116897

Tender notice from USA, published on 29 Jul 2026.

Executive Summary

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | CENTERS FOR DISEASE CONTROL AND PREVENTION has issued a Tender notice for the procurement of a Notice of Intent to Sole Source the Procurement of Weekly Delivery of Turkey, Chicken, Guinea Pig, and Horse Red Blood Cells in the USA. This Tender notice was published on 29 Jul 2026 and is scheduled to close on 04 Aug 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 146116897, while the tender notice number is 75D301-26-R-73503 and Register on the platform.

Key facts

Summary
Notice of Intent to Sole Source the Procurement of Weekly Delivery of Turkey, Chicken, Guinea Pig, and Horse Red Blood Cells
TOT Ref. No.
146116897
Document Ref. No.
75D301-26-R-73503
Country
USA
Notice type
Tender
Competition
ICB
Publication date
29 Jul 2026
Bid deadline
04 Aug 2026
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

This is a combined synopsis/solicitation for a sole-source requirement.
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract for weekly delivery of turkey, chicken, guinea pig, and horse red blood cells (RBCs) under product service code (PSC) 6505-Drugs and Biologicals and North American Industry Classification System (NAICS) code) 325414-Blood derivatives manufacturing, manufactured by Lampire Biological Laboratories for use in hemagglutination inhibition (HI) assays performed by the CDC- National Center for Immunization and Respiratory Diseases (NCIRD)-Influenza Division. The required capability is the ability to consistently provide RBCs with the biological performance characteristics necessary to support validated HI assay methods and maintain continuity of CDC influenza surveillance data.
The required RBCs must be produced using manufacturing, donor sourcing, collection, processing, quality control, and storage practices that yield consistent hemagglutination performance across all required animal species. The products must demonstrate compatibility with the Influenza Division's validated assay protocols and preserve comparability with historical antigenic characterization data used for routine influenza surveillance, FluView reporting, and influenza vaccine strain selection.
Lampire Biological Laboratories is the only known manufacturer whose turkey, chicken, guinea pig, and horse RBCs have been validated for these established CDC HI assay protocols and have consistently demonstrated the performance characteristics required to maintain continuity of longitudinal surveillance data. Use of RBCs from another manufacturer would require extensive validation to establish equivalency and assess impacts on assay performance and historical data comparability. Until such equivalency is demonstrated, no other manufacturer's products will satisfy the Government's minimum requirement to support uninterrupted, cons...
Notice ID: 75d301-26-r-73503

Department/Ind. Agency: health and human services, department of

Sub-tier: centers for disease control and prevention

Office: cdc office of acquisition services

Product Service Code: 6505 - drugs and biologicals

NAICS Code: 325414 - Biological Product (except Diagnostic) Manufacturing

Inactive Dates: aug 05, 2026

Inactive Policy: manual

Documents

Tender Notice
Login to view

Corresponding contract award notice

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for Notice of Intent to Sole Source the Procurement of Weekly Delivery of Turkey, Chicken, Guinea Pig, and Horse Red Blood Cells was 04 Aug 2026. Bidding is closed.

This tender has been issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF | CENTERS FOR DISEASE CONTROL AND PREVENTION in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 146116897. The purchaser document reference is 75D301-26-R-73503.

Browse other tenders from USA or search by relevant keywords and CPV classification.